|
|
||||||||
a Division of Thoracic Surgery, Rush University Medical Center, Chicago, Illinois
b Section of Medical Oncology, Rush University Medical Center, Chicago, Illinois
Accepted for publication April 22, 2009.
* Address correspondence to Dr Liptay, University Thoracic Surgeons, 1725 W Harrison St, Ste 774, Chicago, IL 60612 (Email: michael_liptay{at}rush.edu).
Presented at the Forty-fifth Annual Meeting of The Society of Thoracic Surgeons, San Francisco, CA, Jan 26–28, 2009.
Background: The long-term benefits and risks of pneumonectomy after neoadjuvant chemoradiation therapy remain controversial. This study evaluated our experience with pneumonectomy for advanced non-small cell lung cancer (NSCLC) after concurrent chemoradiation therapy.
Methods: We reviewed medical records from patients undergoing concurrent chemoradiation therapy, followed by pneumonectomy (1983 to 2007). Clinical variables affecting Kaplan-Meier survival were analyzed.
Results: After chemoradiation therapy, 129 pneumonectomies (right, 65; left, 64) were performed. Postoperative pathologic stages were complete responders (CR), 21; I, 23; II, 19; III, 62; and IV, 4. The 90-day perioperative mortality was 20% (13 of 65) after right-sided pneumonectomy vs 9% (6 of 64) after left-sided pneumonectomy (p = 0.084). Complications occurred in 33% (43 of 129), including bronchopleural fistula in 12% (16 of 129) and acute respiratory distress syndrome in 2% (3 of 129). Overall 5-year survival was 33%. Survival was 32% for right-sided sections vs 34% for left-sided. CR patients had a 5-year survival of 48%. Survival of patients with postoperative N0, N1, and N2 nodes was 42%, 26%, and 28%, respectively. Multivariate analysis showed the development of major complications negatively affected 5-year survival for patients undergoing right-sided pneumonectomy (hazard ratio, 0.462; p = 0.0399).
Conclusions: Pneumonectomy after concurrent chemoradiation therapy achieved long-term survival. When neoadjuvant therapy resulted in complete response or nodal downstaging, survival was improved. The risk of early perioperative death and complications was higher for right-sided procedures, but long-term survival did not differ between right- and left-sided pneumonectomy. Major complications negatively affected 5-year survival with right-sided pneumonectomies.
This article has been cited by other articles:
![]() |
A. W. Kim, D. J. Boffa, Z. Wang, and F. C. Detterbeck An analysis, systematic review, and meta-analysis of the perioperative mortality after neoadjuvant therapy and pneumonectomy for non-small cell lung cancer J. Thorac. Cardiovasc. Surg., January 1, 2012; 143(1): 55 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Kim, M. J. Liptay, P. Bonomi, W. H. Warren, S. Basu, E. C. Farlow, and L. P. Faber Neoadjuvant Chemoradiation for Clinically Advanced Non-Small Cell Lung Cancer: An Analysis of 233 Patients Ann. Thorac. Surg., July 1, 2011; 92(1): 233 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Fernandez, S. D. Force, A. Pickens, P. D. Kilgo, T. Luu, and D. L. Miller Impact of Laterality on Early and Late Survival After Pneumonectomy Ann. Thorac. Surg., July 1, 2011; 92(1): 244 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Krasna Reply to the Editor J. Thorac. Cardiovasc. Surg., March 1, 2010; 139(3): 807 - 807. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |